<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<?covid-19-tdm?>
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Int J Public Health</journal-id>
<journal-title>International Journal of Public Health</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Int J Public Health</abbrev-journal-title>
<issn pub-type="epub">1661-8564</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1604994</article-id>
<article-id pub-id-type="doi">10.3389/ijph.2022.1604994</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Public Health Archive</subject>
<subj-group>
<subject>Original Article</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Did COVID-19 Policies Have the Same Effect on COVID-19 Incidence Among Women and Men? Evidence From Spain and Switzerland</article-title>
<alt-title alt-title-type="left-running-head">Sant Fruchtman et al.</alt-title>
<alt-title alt-title-type="right-running-head">Gender Effects of COVID19 Policies</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Sant Fruchtman</surname>
<given-names>Carmen</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1723609/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fischer</surname>
<given-names>Fabienne Beatrice</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Monz&#xf3;n Llamas</surname>
<given-names>Laura</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tavakkoli</surname>
<given-names>Maryam</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1499858/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cobos Mu&#xf1;oz</surname>
<given-names>Daniel</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1550424/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Antillon</surname>
<given-names>Marina</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1813141/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Swiss Tropical and Public Health Institute (Swiss TPH)</institution>, <addr-line>Allschwil</addr-line>, <country>Switzerland</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>University of Basel</institution>, <addr-line>Basel</addr-line>, <country>Switzerland</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Independent Researcher</institution>, <country>Switzerland</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1192487/overview">Michael J. Deml</ext-link>, Universit&#xe9; de Gen&#xe8;ve, Switzerland</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1026554/overview">Daniela Anker</ext-link>, Universit&#xe9; de Fribourg, Switzerland</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Carmen Sant Fruchtman, <email>c.santfruchtman@swisstph.ch</email>; Marina Antillon, <email>marina.antillon@swisstph.ch</email>
</corresp>
<fn fn-type="equal" id="fn1">
<label>
<sup>
<bold>&#x2020;</bold>
</sup>
</label>
<p>These authors have contributed equally to this work</p>
</fn>
<fn fn-type="other" id="fn001">
<p>This Original Article is part of the IJPH Special Issue &#x201c;Responses to the COVID-19 Pandemic: International Comparisons&#x201d;</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>20</day>
<month>09</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>67</volume>
<elocation-id>1604994</elocation-id>
<history>
<date date-type="received">
<day>05</day>
<month>04</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>08</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Sant Fruchtman, Fischer, Monz&#xf3;n Llamas, Tavakkoli, Cobos Mu&#xf1;oz and Antillon.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Sant Fruchtman, Fischer, Monz&#xf3;n Llamas, Tavakkoli, Cobos Mu&#xf1;oz and Antillon</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>
<bold>Objective:</bold> This study aimed to investigate how COVID-19 prevention policies influenced the COVID-19 incidence in men and women.</p>
<p>
<bold>Methods:</bold> We conducted a retrospective longitudinal study using the Swiss Federal Office of Public Health and the Spanish Ministry of Health surveillance data for February 2020&#x2013;June 2021 to explore sex and age differences in COVID-19 cases and testing. The female-male incidence rate ratios (IRR) were estimated for each week of the pandemic. We complemented our analysis with qualitative information on relevant containment measures in each country.</p>
<p>
<bold>Results:</bold> In Switzerland and in Spain, there was an excess of cases in women of 20&#x2013;59&#xa0;years old and 80&#x2b;. This excess of cases was significant during the waves of the pandemic in both countries. In Switzerland, the biggest difference was observed for the age group 20&#x2013;29, reaching an excess of 94% of cases compared to men during the first wave of COVID-19 (March&#x2013;May 2020). The excess of cases in women was greater in Spain than in Switzerland, where it reached 159% for women aged 20&#x2013;29 during the first wave (March&#x2013;June 2020). In both countries, the age groups 60&#x2013;79 had a significant excess of cases in men during the pandemic.</p>
<p>
<bold>Conclusion:</bold> COVID-19 public health policies affect men and women in different ways. Our findings highlight the importance of gender-sensitive responses to address a public health crisis.</p>
</abstract>
<kwd-group>
<kwd>public health</kwd>
<kwd>COVID&#x2013;19</kwd>
<kwd>health policy</kwd>
<kwd>epidemiology</kwd>
<kwd>gender</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Early in 2020, the first reports coming from China and Italy indicated the population group with the highest mortality risk due to the virus were men with comorbidities, which was confirmed globally as the pandemic spread [<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>]. Numerous studies have shown that the impact of the COVID-19 pandemic is gendered: conferring differential risks attributable to both biological differences (sex), but also marked by social dynamics and socially constructed norms (gender) [<xref ref-type="bibr" rid="B3">3</xref>]. Given the differences in mortality, much research and academic commentary has focused on explaining the increased mortality in men compared to women [<xref ref-type="bibr" rid="B4">4</xref>]. Such approaches, however, have failed to address how sex and gender differences affect COVID-19 incidence [<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6</xref>].</p>
<p>Since early in the pandemic, few countries have routinely reported sex-disaggregated data on cases and deaths of COVID-19 [<xref ref-type="bibr" rid="B7">7</xref>]. The countries reporting cases and deaths disaggregated by sex show mostly higher death rates in men and similar incidence for men and women [<xref ref-type="bibr" rid="B5">5</xref>]. Unfortunately, incidence data describing the differential progress of the disease by gender is not routinely collected [<xref ref-type="bibr" rid="B8">8</xref>]. Gender has been described as a multidimensional variable that describes identity, norms and relations between individuals and that can influence access to health services, social support, as well as behaviour towards the prevention of the virus [<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>].</p>
<p>A pre-print published in May 2020 examined the apparent equality between men and women in COVID-19 infection rates adding an age-disaggregated analysis in ten European countries [<xref ref-type="bibr" rid="B11">11</xref>]. The study used routine epidemiological data and reported a higher rate of infections among women compared to men of working-age (20&#x2013;59&#xa0;years old). The difference became non-significant in the population above 60&#xa0;years of age. This finding illustrates the potential role that social norms could have in the spread of COVID-19.</p>
<p>As the pandemic was unfolding, countries worldwide tried to control its peak with strict public health policies that included lockdowns and other restrictions, which started in March 2020 [<xref ref-type="bibr" rid="B12">12</xref>]. Unfortunately, some of these policies reinforced pre-existing inequalities, including gender inequalities [<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B13">13</xref>].</p>
<p>Despite the growing body of evidence showing differences by gender and other social determinants in COVID-19, very few studies have examined how different phases of the pandemic have impacted men and women differentially with a specific focus on COVID-19 incidence and its policy drivers. We explore whether the overall case burden, even in age groups for whom COVID-19 is not usually fatal, shows a similar pattern between men and women and how COVID-19 prevention policies may have affected it.</p>
<p>For this study, we chose to focus on two European countries: Switzerland and Spain, which were among the European countries with the highest numbers of cases and deaths per capita in the first year of the pandemic [<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B15">15</xref>]. Additionally, the countries&#x2019; policies represent different stringency to COVID-19 containment approaches, with Spain going into full &#x201c;lockdown&#x201d; (as in people were not allowed to leave their homes freely) for a considerable time, while Switzerland never went into full lockdown.</p>
</sec>
<sec sec-type="methods" id="s2">
<title>Methods</title>
<p>We conducted a retrospective longitudinal study using quantitative COVID-19 case and testing data and qualitative data on the containment measures and policies between February 2020 and June 2021 in two European countries, Switzerland and Spain.</p>
<sec id="s2-1">
<title>Study Setting</title>
<p>Switzerland is a small federal state in central Europe bordering France, Germany, Austria, the Principality of Liechtenstein and Italy. It is divided into 26 cantons (administrative entities). The Swiss health system is based on universally mandated private health insurance [<xref ref-type="bibr" rid="B16">16</xref>].</p>
<p>Spain, bordering Portugal and France and the microstate of Andorra, consists of 17 autonomous communities, including two island territories. It has a public, universally accessible National Health System complemented by voluntary private insurance policies.</p>
<p>Healthcare is more privatised in Switzerland than in Spain, where it is more socialised. Both countries have universal access to healthcare and a decentralised public health system. However, both had mechanisms to centralise decision making in times of an emergency like COVID-19. The per capita spending on health care in 2018 was 9,870 USD in Switzerland, the second highest in the world, while in Spain it was 2,736 USD [<xref ref-type="bibr" rid="B17">17</xref>].</p>
<p>Both countries ranked similarly in the latest Gender Gap Index: 10th (Switzerland) and 14th (Spain) place out of 156 [<xref ref-type="bibr" rid="B18">18</xref>]. However, despite this high ranking, there are prevailing differences in everyday lives for women and men in these countries. In recent years, men and women have achieved a more balanced participation in the labour market, however, in both countries, most domestic tasks and care work are still predominantly carried out by women in the family context [<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B20">20</xref>]. Even during the lockdown, many women had to consider quitting their jobs to be able to take care of their children, since schools were closed [<xref ref-type="bibr" rid="B21">21</xref>].</p>
<p>In both countries, women tend to have jobs that include physical interactions with people (teaching, childcare, health workers, supermarket employees, etc.), many of which were considered &#x201c;essential&#x201d;, even when most workers were recommended to stay home [<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B22">22</xref>].</p>
</sec>
<sec id="s2-2">
<title>Data Collection and Analysis</title>
<p>To understand how COVID-19 incidence among men and women changed over time, we used publicly available case data stratified by sex and age. Data was collected from the Swiss Federal Office of Public Health (FOPH), as well as the Spanish Red Nacional de Vigilancia Epidemiol&#xf3;gica (RENAVE). COVID-19 cases were mandatory to be notified to the FOPH since before the first case in Switzerland. The case definitions were adapted through time, based on the diagnostic possibilities (changing from PCR-confirmed to rapid test confirmations). Likewise, the definition of a case was updated in Spain according to the technical reports for the COVID-19 case management [<xref ref-type="bibr" rid="B23">23</xref>].</p>
<p>We explored the incidence between men and women from the outbreak of the pandemic (February 2020) until June 2021. We calculated the IRR of cases between women and men, stratified by age groups - for each week of the pandemic:<disp-formula id="equ1">
<mml:math id="m1">
<mml:mrow>
<mml:mi>I</mml:mi>
<mml:mi>R</mml:mi>
<mml:msub>
<mml:mi>R</mml:mi>
<mml:mrow>
<mml:mi>w</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>m</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>n</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>&#x3d;</mml:mo>
<mml:mo>&#xa0;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mfrac bevelled="true">
<mml:mrow>
<mml:mi>C</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>s</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>s</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>a</mml:mi>
<mml:mi>m</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>g</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>w</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>m</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>n</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>o</mml:mi>
<mml:mi>f</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>t</mml:mi>
<mml:mi>h</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>t</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>a</mml:mi>
<mml:mi>g</mml:mi>
<mml:mi>e</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>g</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>u</mml:mi>
<mml:mi>p</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>i</mml:mi>
<mml:mi>n</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>t</mml:mi>
<mml:mi>h</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>t</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>w</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>k</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>P</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>p</mml:mi>
<mml:mi>u</mml:mi>
<mml:mi>l</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>n</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>o</mml:mi>
<mml:mi>f</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>w</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>m</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>n</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>i</mml:mi>
<mml:mi>n</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>t</mml:mi>
<mml:mi>h</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>t</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>a</mml:mi>
<mml:mi>g</mml:mi>
<mml:mi>e</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>g</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>u</mml:mi>
<mml:mi>p</mml:mi>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
<mml:mrow>
<mml:mfrac bevelled="true">
<mml:mrow>
<mml:mi>C</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>s</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>s</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>a</mml:mi>
<mml:mi>m</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>g</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>m</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>n</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>o</mml:mi>
<mml:mi>f</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>t</mml:mi>
<mml:mi>h</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>t</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>a</mml:mi>
<mml:mi>g</mml:mi>
<mml:mi>e</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>g</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>u</mml:mi>
<mml:mi>p</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>i</mml:mi>
<mml:mi>n</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>t</mml:mi>
<mml:mi>h</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>t</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>w</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>k</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>P</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>p</mml:mi>
<mml:mi>u</mml:mi>
<mml:mi>l</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>n</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>o</mml:mi>
<mml:mi>f</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>m</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>n</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>i</mml:mi>
<mml:mi>n</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>t</mml:mi>
<mml:mi>h</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>t</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>a</mml:mi>
<mml:mi>g</mml:mi>
<mml:mi>e</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>g</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>u</mml:mi>
<mml:mi>p</mml:mi>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:math>
</disp-formula>
</p>
<p>For convenience, excess cases per population are shown in two ways: 1) as IRR, 2) as a percentage deviation from equality between both sexes (IRR &#x3d; 1):<disp-formula id="equ2">
<mml:math id="m2">
<mml:mrow>
<mml:mi>P</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>t</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>e</mml:mi>
<mml:mi>x</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>s</mml:mi>
<mml:mi>s</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>i</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>d</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>e</mml:mi>
<mml:mo>&#x3d;</mml:mo>
<mml:mrow>
<mml:mo>{</mml:mo>
<mml:mrow>
<mml:mtable>
<mml:mtr>
<mml:mtd>
<mml:mrow>
<mml:mfrac bevelled="true">
<mml:mn>1</mml:mn>
<mml:mrow>
<mml:mi>I</mml:mi>
<mml:mi>R</mml:mi>
<mml:msub>
<mml:mi>R</mml:mi>
<mml:mrow>
<mml:mi>w</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>m</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>n</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:mfrac>
<mml:mo>&#x2212;</mml:mo>
<mml:mn>1</mml:mn>
<mml:mi mathvariant="normal">,</mml:mi>
</mml:mrow>
</mml:mtd>
<mml:mtd>
<mml:mrow>
<mml:mi>I</mml:mi>
<mml:mi>R</mml:mi>
<mml:msub>
<mml:mi>R</mml:mi>
<mml:mrow>
<mml:mi>w</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>m</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>n</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>&#x3c;</mml:mo>
<mml:mn>0</mml:mn>
<mml:mo>&#xa0;</mml:mo>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mi>E</mml:mi>
<mml:mi>x</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>s</mml:mi>
<mml:mi>s</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>o</mml:mi>
<mml:mi>f</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>m</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>n</mml:mi>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:mtd>
</mml:mtr>
<mml:mtr>
<mml:mtd>
<mml:mrow>
<mml:mi>I</mml:mi>
<mml:mi>R</mml:mi>
<mml:msub>
<mml:mi>R</mml:mi>
<mml:mrow>
<mml:mi>w</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>m</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>n</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>&#x2212;</mml:mo>
<mml:mn>1</mml:mn>
<mml:mi mathvariant="normal">,</mml:mi>
</mml:mrow>
</mml:mtd>
<mml:mtd>
<mml:mrow>
<mml:mi>I</mml:mi>
<mml:mi>R</mml:mi>
<mml:msub>
<mml:mi>R</mml:mi>
<mml:mrow>
<mml:mi>w</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>m</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>n</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>&#x2265;</mml:mo>
<mml:mn>0</mml:mn>
<mml:mo>&#xa0;</mml:mo>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mi>E</mml:mi>
<mml:mi>x</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>s</mml:mi>
<mml:mi>s</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>o</mml:mi>
<mml:mi>f</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>w</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>m</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>n</mml:mi>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:mtd>
</mml:mtr>
</mml:mtable>
</mml:mrow>
</mml:mrow>
</mml:mrow>
</mml:math>
</disp-formula>
</p>
<p>To test for disparities, we used an exact test assuming that incidence is Poisson-distributed. &#x201c;Waves&#x201d; in the COVID-19 pandemic were defined as any time that the test positivity rate exceeded 5%, as defined by the World Health Organization (WHO) [<xref ref-type="bibr" rid="B24">24</xref>].</p>
<p>We collected information from policies (such as Royal Decree in Spain, or the COVID-19 Ordinance in Switzerland) published by the governments for the regulation of tele-working, school closures, which had been previously hypothesised as the biggest drivers behind gender differences, as well as testing strategies that were regularly updated by the Ministry of Health (MoH) in Spain and the FOPH in Switzerland to complement the case data [<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B26">26</xref>]. Two of the authors (FBF and LM) searched publicly available reports such as official government documents/websites or press releases and press conferences of national-level policies and their implementation at the second administrative level (cantons in Switzerland, autonomous communities in Spain) to create a harmonised timeline of policies in each country. This was an extension of the Health Observatory detailed in a previous manuscript [<xref ref-type="bibr" rid="B52">27</xref>]. These data were then visualised to show the duration of policies (for home office recommendations and school closures) and the changes in testing policies.</p>
<p>To account for differences in testing behaviour between men and women, supplemental analyses in Switzerland on testing rates by gender were included and the positivity rate was calculated, stratified by gender. In Spain, testing data stratified by gender was not available.</p>
<p>A simple simulation was performed to calculate the theoretical 95% confidence interval of the positivity rate for women had both genders had the same underlying incidence but women were testing at higher rates. This was done by taking 1,000 Monte Carlo samples from a gamma distribution with shape parameter equal to the cases among men and rate parameter equal to the population of men. Then we sampled from a Poisson distribution with rate parameter equal to the gamma distribution draw times the number of women in the population, and we calculated the simulated positivity-rate by the number of tests done on women in the population.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec id="s3-1">
<title>Switzerland</title>
<sec id="s3-1-1">
<title>COVID-19 Policies Over Time</title>
<p>Switzerland has aimed to strike a balance between limiting the spread of COVID-19 and &#x201c;normalcy&#x201d; in social and economic life. A full lockdown, where leaving the house was legally restricted, has never been implemented. The most stringent measures were issued during the first wave from March to June 2020, which included a closure of schools, shops and all leisure and entertainment facilities [<xref ref-type="bibr" rid="B25">25</xref>]. Schools were closed from the week of 16 March to the week of 4 May 2020 and most of the remaining restrictions were lifted during summer 2020.</p>
<p>The second wave, which peaked at the end of October 2020, yielded more than seven times as many reported cases but had fewer restrictions and a more diverse response. At this stage, decision making was decentralised to the cantons, which contrasted with the first wave where centralization to the Federal Council was enabled after declaring an &#x201c;extraordinary situation&#x201d; as stated in the Epidemics Act [<xref ref-type="bibr" rid="B27">28</xref>].</p>
<p>During the second wave, schools remained open, with the exception of universities and other institutions of tertiary education. The second wave was accompanied by a semi-shutdown in which restaurants and other institutions for social activities remained closed for three&#xa0;months. Employers were mandated to enable home office for their employees, if possible. Despite these interventions, the case numbers decreased only slowly between January and March 2021.</p>
<p>During the first months of the pandemic, testing capacities were limited to high-risk groups or people with severe symptoms (<xref ref-type="sec" rid="s8">Supplementary Figure S1</xref>) [<xref ref-type="bibr" rid="B28">29</xref>]. Over time and with the availability of more tests, these recommendations became more relaxed and all symptomatic people or people with suspected exposures were included in the testing strategy. From June 2020 onwards, the government would pay for tests if indicated by their testing criteria [<xref ref-type="bibr" rid="B29">30</xref>]. By the end of 2020, a rapid antigen test became available and from January 2021, the government agreed to pay for the tests also of asymptomatic people with suspected exposure [<xref ref-type="bibr" rid="B30">31</xref>].</p>
<p>Starting in March 2020, the Federal Council implemented a number of social support measures to lessen the impact of the pandemic on companies and employees, such as compensation of loss of earnings for childcare or quarantine/isolation or short time work compensation.</p>
</sec>
<sec id="s3-1-2">
<title>Incidence by Sex Over Time</title>
<p>In Switzerland, there were distinct peaks of increasing COVID-19 incidence (&#x201c;waves&#x201d;): the first wave in February&#x2013;April 2020, and the second wave began in October 2020, peaking by the end of the month, and remaining at an overall high level until a third wave in 22 March, 2021.</p>
<p>We found that during the waves, women in working ages were significantly overrepresented among all COVID-19 cases (<xref ref-type="fig" rid="F1">Figure 1</xref>). During the first wave, women were overrepresented with an excess of up to 58% among women of working age (20&#x2013;59&#xa0;years of age). The excess during the second wave remained at a lower level with a maximum of 23% among women of working age. In contrast, between the waves, little significant difference between the sexes was observed. This is largely attributable to lower case numbers but when the disparity was statistically significant, it disadvantaged men more than women. In an analysis stratified by age (<xref ref-type="sec" rid="s8">Supplementary Figure S2</xref>), there was a tendency towards a higher excess in women aged 20&#x2013;29&#xa0;years old with 40&#x2013;94% excess in the first wave, 10&#x2013;30% in the second wave, yet only 1&#xa0;week with a significant difference in the third wave. For older working age groups (30&#x2013;39, 40&#x2013;49 and 50&#x2013;59&#xa0;years old) the excess was milder than in the 20&#x2013;29&#xa0;years old age group. This pattern of changing disparity during the course of the pandemic was not observed for the population of retired age, where men were almost consistently overrepresented among the cases and the weeks with strong disparity were more sporadic and not associated with the waves (<xref ref-type="fig" rid="F1">Figure 1</xref>; incidence rate ratios are shown in <xref ref-type="sec" rid="s8">Supplementary Figure S3</xref>). In the more detailed age group analysis (<xref ref-type="sec" rid="s8">Supplementary Figure S2</xref>), we note that among the retired age group (60&#x2013;79&#xa0;years of age), those above 80&#xa0;years old, men show excess cases in the first wave of up to 80%, but in the second wave women show excess incidence of up to 28%.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Disparities by gender, in Switzerland (2020&#x2013;2021)&#x2014;<bold>(A)</bold> Total number of cases per sex per week. Weeks with backgrounds in grey are weeks where the positivity rate was &#x3e;5%, the definition of a &#x201c;wave&#x201d; in this paper. The gray lines correspond to the % of tests that were positive for that week (right-axis). <bold>(B)</bold> Percent excess in incidence among men (in blue) or among women (in red) by week and by age group. The working age group constitutes ages 20&#x2013;59 and the retired age group constitutes ages 60&#x2013;79. People over age 80 were excluded. Weeks marked in white did not have statistically significant differences in the incidence rate ratio between the sexes. <bold>(C)</bold> Work from home policies, color-coded for stringency. <bold>(D)</bold> School policies.</p>
</caption>
<graphic xlink:href="ijph-67-1604994-g001.tif"/>
</fig>
<p>In order to assess if our findings were due to testing bias, we analysed testing patterns by sex (<xref ref-type="fig" rid="F2">Figure 2</xref>). The COVID-19 testing rate by sex was only available after the week of 25 May 2020, hence after the first wave. While women were being tested more often than men were, the positivity rate for both men and women was at a comparable level throughout our study period (<xref ref-type="fig" rid="F2">Figure 2</xref>), and the women&#x2019;s positivity rate was higher than we would expect if the underlying incidence rate was equal to that of the men (<xref ref-type="sec" rid="s8">Supplementary Figure S4</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Disparities in testing by gender&#x2014;(Switzerland. 2020&#x2013;2021). <bold>(A)</bold> Proportion of tests taken by women. The grey dashed line at 0.5 represents the line at which men and women are testing in equal numbers. <bold>(B)</bold> Proportion of tests among men and women that are positive for COVID-19. We could not perform this analysis from 24 February, when the first case was reported, until the week of 25 May when the positivity rate was first reported stratified by gender. The gray dashed line at 5% represents the WHO-recommended threshold for defining a wave.</p>
</caption>
<graphic xlink:href="ijph-67-1604994-g002.tif"/>
</fig>
</sec>
</sec>
<sec id="s3-2">
<title>Spain</title>
<sec id="s3-2-1">
<title>COVID-19 Policies Over Time</title>
<p>In Spain, after the announcement of community transmission, several policy measures were put in place to contain the epidemic (<xref ref-type="fig" rid="F3">Figure 3</xref>). Spain was one of the countries with the most stringent measurements during the first wave. Between March and April 2020 a full lockdown was implemented. Only workers in specific sectors (such as healthcare or retail sector) that were considered essential were allowed to leave their houses. From 9 March, face-to-face education was suspended until September 2020.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Disparities by gender, in Spain (2020&#x2013;2021)&#x2014;<bold>(A)</bold> Total number of cases per sex per week. Weeks with backgrounds in grey are weeks where the positivity rate was &#x3e;5%, the definition of a &#x201c;wave&#x201d; in this paper. The gray lines correspond to the % of tests that were positive for that week (right-axis). <bold>(B)</bold> Percent excess in incidence among men (in blue) or among women (in red) by week and by age group. The working age group constitutes ages 20&#x2013;59 and the retired age group constitutes ages 60&#x2013;79. People over age 80 were excluded. Weeks marked in white did not have any statistically significant differences in the incidence rate ratio between the sexes. <bold>(C)</bold> Work from home policies, color-coded for stringency. <bold>(D)</bold> School policies.</p>
</caption>
<graphic xlink:href="ijph-67-1604994-g003.tif"/>
</fig>
<p>Starting on the week of 16 March, teleworking was generally recommended. Between the weeks of 30 March and 6 April, with a total lockdown, all non-essential activities ceased. At that time, health professionals were the most exposed to COVID-19 [<xref ref-type="bibr" rid="B31">32</xref>]. After this date, although home office was recommended, the law did not force companies to facilitate it, leaving this decision entirely up to the employer.</p>
<p>COVID-19 testing was implemented nationwide from 13 March (<xref ref-type="sec" rid="s8">Supplementary Figure S4</xref>). However, until 7 May testing was only limited to severe cases of COVID-19 presenting at the emergency department or admitted to the hospital. Health professionals and workers in essential services were also classified as priority populations for testing. Patients with mild and moderate symptoms who were monitored at home or residents in nursing homes were not tested and thus not counted in official statistics of confirmed cases [<xref ref-type="bibr" rid="B32">33</xref>]. A study suggested that the lack of tests of non-hospitalized patients could lead to underreporting of cases in women [<xref ref-type="bibr" rid="B33">34</xref>]. After 4 May, PCR tests became available for all suspected cases.</p>
<p>Since 28 April 2020, the public health restrictions were slowly lifted and the responsibilities fully devolved to the autonomous communities in a co-governance system. Several waves have been reported since summer 2020: a second wave in October 2020, a third wave in January 2021, and a fourth wave after an intense vaccination campaign between January and June 2021.</p>
</sec>
<sec id="s3-2-2">
<title>Incidence by Sex Over Time</title>
<p>Our results show that the most significant gender disparity in relation to COVID-19 incidence was during the first wave in working age groups, reaching an excess of female cases of up to 108% (<xref ref-type="fig" rid="F3">Figure 3</xref>; incidence rate ratios are shown in <xref ref-type="sec" rid="s8">Supplementary Figure S6</xref>). In the detailed age group analysis, we note that the excess is even more pronounced in the 20&#x2013;29 and 30&#x2013;39 years-old age groups (<xref ref-type="sec" rid="s8">Supplementary Figure S5</xref>). The excess of female incidence remained during the following peaks, albeit at a lower level, reaching a maximum excess of 18%. In contrast, in the retired age group (60&#x2013;79&#xa0;years of age) data shows an excess of male case incidence (reaching 87% of excess) before the week of 6 April 2020. However, this trend changes dramatically in the 80&#x2b; age group, where, between the weeks of 6 April through 15 June, the excess of female cases reached 102% (<xref ref-type="sec" rid="s8">Supplementary Figure S5</xref>). After the first wave, there is no significant gender disparity among the retired age groups (less than 12% excess of male cases).</p>
</sec>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>Gender differences in relation to COVID-19 incidence rates have been previously discussed, given the higher risk of mortality and hospitalisation in men [<xref ref-type="bibr" rid="B34">35</xref>]. However, less attention has been given to the sex-differential impact of public health response on COVID-19 case incidence rates. The COVID-19 burden goes beyond mortality and short-term illness [<xref ref-type="bibr" rid="B35">36</xref>]. Women have been shown to be four times as likely than men to suffer from at least one persisting symptom after a COVID-19 infection for an extended period [<xref ref-type="bibr" rid="B36">37</xref>].</p>
<p>Global data suggested a similar case burden in women and men during the first year of the pandemic [<xref ref-type="bibr" rid="B37">38</xref>]. Our study shows, however, that in Spain and in Switzerland, during the waves in 2020 and the first half of 2021, more women were diagnosed with COVID-19 than men. Testing data from Switzerland suggests that this phenomenon is not due to differential test-seeking behaviour between the genders, but rather different incidence (<xref ref-type="fig" rid="F2">Figure 2</xref>), as the positivity rate was similar in both groups. Yet, higher infection rates in women are only present for the populations of working age (20&#x2013;59&#xa0;years old) and above 80&#xa0;years old (<xref ref-type="sec" rid="s8">Supplementary Figure S2</xref>). In a previous study, Sobotka et al. also found a higher rate of cases in women compared to men, for the working age group [<xref ref-type="bibr" rid="B11">11</xref>].</p>
<p>The difference in the stringency of the containment measures between the waves studied seemed to be associated with a different degree of disparity, which could be read similar to a &#x201c;dose response&#x201d; relationship. The more stringent the measures, the larger the gender disparity, which could explain the differences seen between Switzerland and Spain; in Switzerland, where the measures were less stringent, the gender disparity in cases was lower than in Spain.</p>
<p>The WHO&#x2019;s sex and gender in infectious diseases framework [<xref ref-type="bibr" rid="B38">39</xref>] describes the interaction of sex and gender with infectious diseases at three different levels: 1) vulnerability to the disease, 2) ability to prevent exposure and 3) decision-making power.</p>
<p>It has been hypothesised before that women are more exposed than men to COVID-19, be it in the domestic or professional setting [<xref ref-type="bibr" rid="B39">40</xref>]. Paradoxically, women also self-reported higher compliance with containment measures (namely social distancing and hygiene) [<xref ref-type="bibr" rid="B40">41</xref>]. Therefore, even though women aim to act responsibly, they are limited in their ability to prevent exposure. They are subject to more frequent or more precarious exposures than men, which would explain what we observed in Switzerland and in Spain. We discuss below the potential causal pathways between the implementation of COVID-19 prevention policies and the differential protective effect in men and women.</p>
<sec id="s4-1">
<title>Women Were More Exposed to COVID-19 at Work</title>
<p>In Switzerland, when home office policies were established (recommended from 13 March&#x2013;6 June, 2020, 19 October&#x2013;4 December 2020, and starting on 26 June 2021; but moderately or strongly advised from 4 December 2020&#x2013;26 June 2021) the excess of cases among women increased significantly. However, when we looked at the degree of stringency and the degree of excess cases among women, it suggests that it is the school closure during the first wave that is associated with the excess among women, whereas in the more severe second wave, schools remained open for younger children, and the excess among women was milder (<xref ref-type="fig" rid="F1">Figure 1</xref>). A similar situation was observed in Spain, where an excess of cases was observed among the women of working age, and more marked among women of typically child-bearing age during the closure of schools and day care centres (<xref ref-type="fig" rid="F3">Figure 3</xref>).</p>
<p>During the first wave the stringency of policies differed in Switzerland and Spain: while in Switzerland a &#x201c;soft-lockdown&#x201d; was applied, citizens in Spain were forced to stay at home. Face-to-face education at schools and universities were suspended in both countries. Exceptions to the norms of staying and working from home were issued in Switzerland as well as in Spain for workers in sectors considered &#x201c;essential&#x201d;. Essential services included those ensuring supply of food and hygiene products, medicines, health care, transport or security [<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B41">42</xref>]. Workers in these sectors are predominantly women in both countries [<xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B41">42</xref>, <xref ref-type="bibr" rid="B42">43</xref>]. For context, in Switzerland 68% of the health workforce, 92% of childcare and 67% of retail positions are staffed by women [<xref ref-type="bibr" rid="B22">22</xref>]. Similarly, in Spain, more than 70% of the health professionals are women and they are also overrepresented in sectors like social work, retail, health and cleaning services [<xref ref-type="bibr" rid="B41">42</xref>]. Studies have shown that workers in some industries, such as meat factories, were predominantly male and at higher risk of contracting COVID-19 due to superspreading events [<xref ref-type="bibr" rid="B43">44</xref>]. However, in the case of Spain and Switzerland, these occupations account for a smaller volume of workers than the health, educational and care sectors, where women are overrepresented.</p>
<p>There is little to no evidence in both countries on case burden by sex and occupation. However, several studies have shown a higher case burden among the health workforce. Furthermore, Perez-Romero et al. found that most health and social care professionals in several high incidence areas in Spain were infected in their workplaces, while the general population were infected mostly at home [<xref ref-type="bibr" rid="B44">45</xref>]. One study in Switzerland found increased seroprevalence in hospitals treating COVID-19 patients compared to hospitals without COVID-19 patients, but overall only a small difference between healthcare workers and the general population was observed [<xref ref-type="bibr" rid="B45">46</xref>].</p>
</sec>
<sec id="s4-2">
<title>Care-Giving in Switzerland and Spain</title>
<p>Evidence suggests that women were not only more exposed at work, they were also more exposed to the virus at home compared to men. In Switzerland, women take on more of the unpaid care work than men (31.2% of women reported to take care of either children, adults or both compared to 11.6% of men) [<xref ref-type="bibr" rid="B46">47</xref>]. In both countries, if a family member gets ill, it has been shown that the closest care (with the highest infection risks) falls to the women of the household [<xref ref-type="bibr" rid="B47">48</xref>]. Additionally, most (known) transmissions in Switzerland happened within households [<xref ref-type="bibr" rid="B45">46</xref>].</p>
<p>The closure of schools and nursery homes implied that two out of three mothers had to stay at home in Spain, shouldering the highest burden of domestic and care work [<xref ref-type="bibr" rid="B21">21</xref>]. Moreover, the additional burden on women due to caregiving activities did not only increase their risk to contract the virus, but it also led to additional secondary effects, such as loss of jobs.</p>
</sec>
<sec id="s4-3">
<title>Over-Representation of Women in Nursing Homes</title>
<p>Finally, our results also show that women above 80&#xa0;years old were at higher risk of contracting the disease than men in the same age group. The difference was, however, more prominent in Spain (<xref ref-type="sec" rid="s8">Supplementary Figures S2 vs. S6</xref>), where the difference was maintained throughout the pandemic, reaching 102% of infections in April 2020. The Spanish MoH estimates that almost 20 thousand people died between January and June 2020&#xa0;in nursing homes nationwide due to COVID-19, where most of the residents are women [<xref ref-type="bibr" rid="B21">21</xref>]. Several studies and media reports addressed the problem of nursing homes during the COVID-19 pandemic, as elderly people were abandoned by the State, leaving especially old women in a vulnerable situation [<xref ref-type="bibr" rid="B48">49</xref>].</p>
<p>Switzerland could have faced similar challenges, as there was an excess of COVID-19 cases in women above 80&#xa0;years old during the second wave of the pandemic (November 2020&#x2013;January 2021). According to the Swiss Federal Statistical Office, in 2020, 1.8% of the Swiss population lived in care homes (either short-term or long-term), and among those living in care homes 67% are women [<xref ref-type="bibr" rid="B49">50</xref>]. In a recently published report, an increase of 80% of deaths in care homes was reported during autumn of 2020 [<xref ref-type="bibr" rid="B50">51</xref>]. The press release does not differentiate, however, between deaths of men and women. Our study findings, which show an excess of cases in women over age 80 in the second wave (<xref ref-type="sec" rid="s8">Supplementary Figure S2</xref>), highlight the importance of understanding if this increase of deaths was attributable to transmission within care homes.</p>
<p>We hypothesize that the reason for the overrepresentation of women in old-age nursing homes is partly an overall decline in the proportion of men with increasing age, but also that women of that age have often lost their partners, while men could potentially benefit from at-home care from their wives or partners [<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B51">52</xref>]. This circumstance could be attributed to the fact that men tend to have younger partners and a lower life expectancy.</p>
<p>The COVID-19 crisis has affected everyone, but in different ways. Social determinants and inequalities have been described as key factors behind the drivers of this pandemic. Social determinants have influenced the risk of contracting the disease, the outcomes of it, as well as the unintended effects of the containment measures [<xref ref-type="bibr" rid="B51">52</xref>]. Our findings for two exemplary countries, Spain and Switzerland, suggest that the differences in the sex-ratio of cases are not only due to biological differences, but rather to social and gender norms and how policies affected population groups differently. These associations were seen despite both of our selected countries ranking high in the Global Gender Gap report; it is likely that our findings are transferable to many other countries.</p>
</sec>
<sec id="s4-4">
<title>Limitations</title>
<p>Our results are probably showing an underrepresentation of disparities, given changing testing policies. Until May 2020, the testing strategy only covered inpatients and severe cases, which were borne in a slightly higher proportion by elderly men. Furthermore, data on testing disaggregated by both age and sex were not available for either country.</p>
</sec>
<sec id="s4-5">
<title>Conclusion</title>
<p>Our study shows that while the mortality of COVID-19 is disadvantageous to men, the incidence of COVID-19 disproportionately burdens women, in particular women of child-bearing and working age (20&#x2013;59&#xa0;years old). This has long-term implications due to fourfold higher odds of developing &#x201c;long COVID&#x201d; borne by women.</p>
<p>Evidence is emerging about the protective benefits and effectiveness of certain policies and non-pharmaceutical interventions to reduce COVID-19 incidence. These studies are, however, often looking at overall numbers and may overlook how policies may reduce the risk differently among population groups, including those defined by gender. When different effects are observed this is often attributed to the levels of compliance, rather than structural exposures or risks that are unaddressed by the policies. We argue that there is a need to search for drivers beyond compliance and understand how policies enable certain groups to shield from the pandemic more than others.</p>
<p>Policy and decision-makers have embedded gender in their discourse, but this has often been limited to rhetoric or implementing policies to alleviate socioeconomic effects of the pandemic. Our study highlights that a gender perspective is also crucial to implement incidence-prevention measures, like non-pharmaceutical interventions.</p>
</sec>
</sec>
</body>
<back>
<sec id="s5">
<title>Ethics Statement</title>
<p>Ethical review and approval was not required for the study on human participants in accordance with the local legislation and institutional requirements. Written informed consent for participation was not required for this study in accordance with the national legislation and the institutional requirements.</p>
</sec>
<sec id="s6">
<title>Author Contributions</title>
<p>All authors contributed to the design of the study. CS and MA designed the data collection, FBF and LM conducted the data collection. MA led the analysis. CS wrote the first outline of the manuscript and all authors contributed to sections of it. All authors reviewed and approved the last version of the manuscript.</p>
</sec>
<sec sec-type="COI-statement" id="s7">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s8">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.ssph-journal.org/articles/10.3389/ijph.2022.1604994/full#supplementary-material">https://www.ssph-journal.org/articles/10.3389/ijph.2022.1604994/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material>
<label>Supplementary Figure S1</label>
<caption>
<p>Testing policies in Switzerland. Dates are listed along the x-axis, and vertical lines indicate the date when the policy was implemented. RDT tests were available in Switzerland since 18 December 2020, but only for screening purposes. Confirmation of a case was only possible through PCR (Switzerland. 2020-2021).</p>
</caption>
</supplementary-material>
<supplementary-material>
<label>Supplementary Figure S2</label>
<caption>
<p>Disparities by gender, detailed (Switzerland. 2020-2021). <bold>(A)</bold> Total number of cases per sex per week. Weeks with backgrounds in gray are weeks where the positivity rate was &#x3e;5%, the definition of a &#x201c;wave&#x201d; in this paper. <bold>(B)</bold> Percent excess in incidence among men (in blue) or among women (in red) by week and by detailed age group. Weeks marked in white did not have any statistically significant differences in the incidence rate ratio between the sexes.</p>
</caption>
</supplementary-material>
<supplementary-material>
<label>Supplementary Figure S3</label>
<caption>
<p>Incidence rate ratio for COVID-19 cases among women compared to men by week from February 2020&#x2013;June 2021 and stratified for working age groups and retired age groups (Switzerland. 2020-2021). The solid lines represent the weeks for which the IRR is statistically significant (<italic>p</italic> &#x3c; 0.05) and the shaded lines represent the weeks for which the IRR is not statistically significant.</p>
</caption>
</supplementary-material>
<supplementary-material>
<label>Supplementary Figure S4</label>
<caption>
<p>Sensitivity analysis of testing positivity rate in Switzerland if men and women had the same incidence rate but different testing rates. The gray ribbon shows the expected positivity rate for women when men's incidence rates were applied (Switzerland 2020&#x2013;2021).</p>
</caption>
</supplementary-material>
<supplementary-material>
<label>Supplementary Figure S5</label>
<caption>
<p>Testing policies in Spain. Dates are listed along the x-axis, and grey vertical lines indicate the date when the policy was implemented. RDT tests were available in Spain since 7 December 2020, but only for screening purposes. Confirmation of a case was only possible through PCR. (Spain. 2020&#x2013;2021).</p>
</caption>
</supplementary-material>
<supplementary-material>
<label>Supplementary Figure S6</label>
<caption>
<p>Disparities by gender, detailed (Spain. 2020&#x2013;2021). <bold>(A)</bold> Total number of cases per sex per week. Weeks with backgrounds in gray are weeks where the positivity rate was &#x3e;5%, the definition of a &#x201c;wave&#x201d; in this paper. <bold>(B)</bold> Percent excess in incidence among men (in blue) or among women (in red) by week and by detailed age group. Weeks marked in white did not have any statistically significant differences in the incidence rate ratio between the sexes.</p>
</caption>
</supplementary-material>
<supplementary-material>
<label>Supplementary Figure S7</label>
<caption>
<p>Incidence rate ratio for COVID-19 cases among women compared to men by week from February 2020&#x2013;June 2021 and stratified for working age groups and retired age groups (Spain. 2020&#x2013;2021). The solid lines represent the weeks for which the IRR is statistically significant (<italic>p</italic> &#x3c; 0.05) and the shaded lines represent the weeks for which the IRR is not statistically significant.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Image5.PNG" id="SM1" mimetype="application/PNG" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Image4.PNG" id="SM2" mimetype="application/PNG" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Image7.png" id="SM3" mimetype="application/png" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Image2.PNG" id="SM4" mimetype="application/PNG" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Image1.PNG" id="SM5" mimetype="application/PNG" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Image6.PNG" id="SM6" mimetype="application/PNG" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Image3.PNG" id="SM7" mimetype="application/PNG" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peckham</surname>
<given-names>H</given-names>
</name>
<name>
<surname>de Gruijter</surname>
<given-names>NM</given-names>
</name>
<name>
<surname>Raine</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Radziszewska</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ciurtin</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wedderburn</surname>
<given-names>LR</given-names>
</name>
<etal/>
</person-group> <article-title>Male Sex Identified by Global COVID-19 Meta-Analysis as a Risk Factor for Death and ITU Admission</article-title>. <source>Nat Commun</source> (<year>2020</year>) <volume>11</volume>(<issue>1</issue>):<fpage>6317</fpage>&#x2013;<lpage>0</lpage>. <pub-id pub-id-type="doi">10.1038/s41467-020-19741-6</pub-id> </citation>
</ref>
<ref id="B2">
<label>2.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Bendix</surname>
<given-names>A</given-names>
</name>
</person-group>. <source>One Chart Shows Wuhan&#x27;s Coronavirus Deaths by Age and Sex. The Most Deaths Were Among Men in Their 60s</source> (<year>2020</year>). </citation>
</ref>
<ref id="B3">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tadiri</surname>
<given-names>CP</given-names>
</name>
<name>
<surname>Gisinger</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kautzy-Willer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kublickiene</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Herrero</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Raparelli</surname>
<given-names>V</given-names>
</name>
<etal/>
</person-group> <article-title>The Influence of Sex and Gender Domains on COVID-19 Cases and Mortality</article-title>. <source>Can Med Assoc J</source> (<year>2020</year>) <volume>192</volume>(<issue>36</issue>):<fpage>E1041</fpage>&#x2013;<lpage>E1045</lpage>. <pub-id pub-id-type="doi">10.1503/cmaj.200971</pub-id> </citation>
</ref>
<ref id="B4">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sofia</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Dumanski</surname>
<given-names>SM</given-names>
</name>
</person-group>. <article-title>Sex, Gender and COVID-19: a Call to Action</article-title>. <source>Can J Public Health</source> (<year>2020</year>) <volume>111</volume>(<issue>6</issue>):<fpage>980</fpage>&#x2013;<lpage>3</lpage>. <pub-id pub-id-type="doi">10.17269/s41997-020-00417-z</pub-id> </citation>
</ref>
<ref id="B5">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Fox</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bae</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Is the Male Disadvantage Real? Cross-National Variations in Sex Gaps in COVID-19 Incidence and Mortality</article-title>. <source>Glob Public Health</source> (<year>2021</year>) <volume>16</volume>:<fpage>1793</fpage>&#x2013;<lpage>803</lpage>. <pub-id pub-id-type="doi">10.1080/17441692.2021.1981972</pub-id> </citation>
</ref>
<ref id="B6">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Womersley</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ripullone</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Peters</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Woodward</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Covid-19: Male Disadvantage Highlights the Importance of Sex Disaggregated Data</article-title>. <source>BMJ</source> (<year>2020</year>) <volume>370</volume>:<fpage>m2870</fpage>. <pub-id pub-id-type="doi">10.1136/bmj.m2870</pub-id> </citation>
</ref>
<ref id="B7">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hawkes</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pantazis</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gautam</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kiwuwa-Muyingo</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Buse</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group> <article-title>Recorded but Not Revealed: Exploring the Relationship between Sex and Gender, Country Income Level, and COVID-19</article-title>. <source>Lancet Glob Health</source> (<year>2021</year>) <volume>9</volume>(<issue>6</issue>):<fpage>e751</fpage>&#x2013;<lpage>e752</lpage>. <pub-id pub-id-type="doi">10.1016/S2214-109X(21)00170-4</pub-id> </citation>
</ref>
<ref id="B8">
<label>8.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Perret</surname>
<given-names>M</given-names>
</name>
</person-group>. <source>COVID-19 Data on Trans and Gender-Expansive People, Stat!</source>. <publisher-loc>United States</publisher-loc>: <publisher-name>Forefront Group, Health Affairs Blog</publisher-name> (<year>2021</year>). <pub-id pub-id-type="doi">10.1377/hblog20210510.756668</pub-id> </citation>
</ref>
<ref id="B9">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morgan</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Griffith</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Logie</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Mwiine</surname>
<given-names>AA</given-names>
</name>
<etal/>
</person-group> <article-title>Beyond a Zero-Sum Game: How Does the Impact of COVID-19 Vary by Gender?</article-title> <source>Front Sociol</source> (<year>2021</year>) <volume>6</volume>:<fpage>650729</fpage>. <pub-id pub-id-type="doi">10.3389/fsoc.2021.650729</pub-id> </citation>
</ref>
<ref id="B10">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wenham</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Morgan</surname>
<given-names>RJTL</given-names>
</name>
</person-group>. <article-title>COVID-19: the Gendered Impacts of the Outbreak</article-title>. <source>Lancet</source> (<year>2020</year>) <volume>395</volume>(<issue>10227</issue>):<fpage>846</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(20)30526-2</pub-id> </citation>
</ref>
<ref id="B11">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sobotka</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Brzozowska</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Muttarak</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Zeman</surname>
<given-names>K</given-names>
</name>
<name>
<surname>di Lego</surname>
<given-names>V</given-names>
</name>
</person-group>. <article-title>Age, Gender and COVID-19 Infections</article-title>. <source>medRxiv</source> (<year>2020</year>). <pub-id pub-id-type="doi">10.1101/2020.05.24.20111765</pub-id> </citation>
</ref>
<ref id="B12">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haldane</surname>
<given-names>V</given-names>
</name>
<name>
<surname>De Foo</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Abdalla</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group> <article-title>Health Systems Resilience in Managing the COVID-19 Pandemic: Lessons from 28 Countries</article-title>. <source>Nat Med</source> (<year>2021</year>) <volume>27</volume>(<issue>6</issue>):<fpage>964</fpage>&#x2013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1038/s41591-021-01381-y</pub-id> </citation>
</ref>
<ref id="B13">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Riou</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Panczak</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Althaus</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Junker</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Perisa</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Schneider</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group> <article-title>Socioeconomic Position and the COVID-19 Care cascade from Testing to Mortality in Switzerland: a Population-Based Analysis</article-title>. <source>Lancet Public Health</source> (<year>2021</year>) <volume>6</volume>(<issue>9</issue>):<fpage>e683</fpage>&#x2013;<lpage>e691</lpage>. <pub-id pub-id-type="doi">10.1016/S2468-2667(21)00160-2</pub-id> </citation>
</ref>
<ref id="B14">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Royo</surname>
<given-names>S</given-names>
</name>
</person-group>. <article-title>Responding to COVID&#x2010;19: The Case of Spain</article-title>. <source>Eur Pol Anal</source> (<year>2020</year>) <volume>6</volume>(<issue>2</issue>):<fpage>180</fpage>&#x2013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1002/epa2.1099</pub-id> </citation>
</ref>
<ref id="B15">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moser</surname>
<given-names>A</given-names>
</name>
<name>
<surname>von Wyl</surname>
<given-names>V</given-names>
</name>
<name>
<surname>H&#xf6;glinger</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Health and Social Behaviour through Pandemic Phases in Switzerland: Regional Time-Trends of the COVID-19 Social Monitor Panel Study</article-title>. <source>PLoS One</source> (<year>2021</year>) <volume>16</volume>(<issue>8</issue>):<fpage>e0256253</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0256253</pub-id> </citation>
</ref>
<ref id="B16">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Biller-Andorno</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Zeltner</surname>
<given-names>T</given-names>
</name>
</person-group>. <article-title>Individual Responsibility and Community Solidarity--The Swiss Health Care System</article-title>. <source>N Engl J Med</source> (<year>2015</year>) <volume>373</volume>(<issue>23</issue>):<fpage>2193</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMp1508256</pub-id> </citation>
</ref>
<ref id="B17">
<label>17.</label>
<citation citation-type="book">
<collab>World Bank</collab>. <source>Current Health Expenditure Per Capita (Current US$)</source>. <publisher-loc>Switzerland, Spain</publisher-loc> (<year>2022</year>). </citation>
</ref>
<ref id="B18">
<label>18.</label>
<citation citation-type="book">
<collab>The World Economic Forum</collab>. <source>Global Gender Gap Report 2021</source>. <publisher-loc>Geneva, Switzerland</publisher-loc>: <publisher-name>The World Economic Forum</publisher-name> (<year>2021</year>). </citation>
</ref>
<ref id="B19">
<label>19.</label>
<citation citation-type="book">
<collab>Bundesamt f&#xfc;r Statistik</collab>. <source>Personen in Alters- und Pflegeheimen 2017</source>. <publisher-loc>Bern, Switzerland</publisher-loc>: <publisher-name>Bundesamt f&#xfc;r Statistik</publisher-name> (<year>2017</year>). </citation>
</ref>
<ref id="B20">
<label>20.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Ministerio de Igualdad</surname>
<given-names>S</given-names>
</name>
</person-group>. <source>The Gender Approach, Key in COVID-19 Response</source>. <publisher-loc>Madrid, Spain</publisher-loc>: <publisher-name>Ministerio de Igualdad Espana</publisher-name> (<year>2020</year>). </citation>
</ref>
<ref id="B21">
<label>21.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Hupkau</surname>
<given-names>C</given-names>
</name>
</person-group>. <source>Covid-19 and Gender Inequality in Spain</source>. <volume>Vol. 24</volume>. <publisher-loc>Barcelona, Spain</publisher-loc>: <publisher-name>EsadeEcPol</publisher-name> (<year>2020</year>). p. <fpage>18</fpage>. <comment>Compartir</comment>. </citation>
</ref>
<ref id="B22">
<label>22.</label>
<citation citation-type="web">
<person-group person-group-type="author">
<name>
<surname>Nina H&#xfc;sser</surname>
<given-names>TF</given-names>
</name>
</person-group>. <article-title>Corona-Krise: Eine feministische Analyse und ein feministischer Aufbruch</article-title> (<year>2020</year>). <comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.denknetz.ch/wp-content/uploads/2020/04/2020_Corona-Krise_-Feministische-Analyse-und-feministischer-Aufbruch_def.pdf">http://www.denknetz.ch/wp-content/uploads/2020/04/2020_Corona-Krise_-Feministische-Analyse-und-feministischer-Aufbruch_def.pdf</ext-link>
</comment> (<comment>Accessed March 13, 2022</comment>). </citation>
</ref>
<ref id="B23">
<label>23.</label>
<citation citation-type="web">
<person-group person-group-type="author">
<name>
<surname>Ministerio de Sanidad</surname>
<given-names>S</given-names>
</name>
</person-group>. <article-title>Indicadores Principales de Seguimiento de COVID-19</article-title> (<year>2021</year>). <comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://www.sanidad.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/situacionActual.htm">https://www.sanidad.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/situacionActual.htm</ext-link>
</comment> (<comment>Accessed February 15, 2022</comment>). </citation>
</ref>
<ref id="B24">
<label>24.</label>
<citation citation-type="book">
<collab>World Health Organization</collab>. <source>Public Health Criteria to Adjust Public Health and Social Measures in the Context of COVID-19: Annex to Considerations in Adjusting Public Health and Social Measures in the Context of COVID-19, 12 May 2020</source>. <publisher-loc>Geneva, Switzerland</publisher-loc>: <publisher-name>World Health Organization</publisher-name> (<year>2020</year>). </citation>
</ref>
<ref id="B25">
<label>25.</label>
<citation citation-type="book">
<collab>The Swiss Federal Council</collab>. <source>Ordinance 3 of 19 June 2020 on Measures to Combat the Coronavirus (COVID-19) in (COVID-19 Ordinance 3) (818.101.24)</source>. <publisher-loc>Bern, Switzerland</publisher-loc>: <publisher-name>The Swiss Federal Council</publisher-name> (<year>2020</year>). </citation>
</ref>
<ref id="B26">
<label>26.</label>
<citation citation-type="book">
<collab>Evoluci&#xf3;n de la gesti&#xf3;n de la crisis en Espa&#xf1;a</collab>. <source>COVID-19 Health Crisis. Regulations and Useful Information. 2021 2022</source> (<year>2022</year>). <comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://administracion.gob.es/pag_Home/en/atencionCiudadana/Crisis-sanitaria-COVID-19.html">https://administracion.gob.es/pag_Home/en/atencionCiudadana/Crisis-sanitaria-COVID-19.html</ext-link>
</comment> (<comment>Accessed February 15, 2022</comment>). </citation>
</ref>
<ref id="B52">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tavakkoli</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Karim</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fischer</surname>
<given-names>FB</given-names>
</name>
<name>
<surname>Monzon Llamas</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Raoofi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zafar</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group> <article-title>From Public Health Policy to Impact for COVID-19: A Multi-Country Case Study in Switzerland, Spain, Iran and Pakistan</article-title>. <source>Int J Public Health</source> (<year>2022</year>) <volume>67</volume>:<fpage>1604969</fpage>. <pub-id pub-id-type="doi">10.3389/ijph.2022.1604969</pub-id> </citation>
</ref>
<ref id="B27">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Francetic</surname>
<given-names>I</given-names>
</name>
</person-group>. <article-title>Bad Law or Implementation Flaws? Lessons from the Implementation of the New Law on Epidemics during the Response to the First Wave of COVID-19 in Switzerland</article-title>. <source>Health Policy</source> (<year>2021</year>) <volume>125</volume>(<issue>10</issue>):<fpage>1285</fpage>&#x2013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/j.healthpol.2021.08.004</pub-id> </citation>
</ref>
<ref id="B28">
<label>29.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Bundesrat</surname>
<given-names>S</given-names>
</name>
</person-group>. <source>Point de presse 02.04.2020</source>. <publisher-loc>Bern, Switzerland</publisher-loc>: <publisher-name>Bundesrat Schweiz</publisher-name> (<year>2020</year>). <comment>27 June 2022</comment>. </citation>
</ref>
<ref id="B29">
<label>30.</label>
<citation citation-type="web">
<collab>The Federal Council</collab>. <article-title>Coronavirus: Federal Government to Assume Test Costs, SwissCovid App to Start on 25 June</article-title> (<year>2020</year>). <comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://www.admin.ch/gov/en/start/documentation/media-releases.msg-id-79584.html">https://www.admin.ch/gov/en/start/documentation/media-releases.msg-id-79584.html</ext-link> (Cited July 06, 2022)</comment> (<comment>Accessed March 11, 2022</comment>). </citation>
</ref>
<ref id="B30">
<label>31.</label>
<citation citation-type="web">
<collab>The Federal Council</collab>. <article-title>Coronavirus: Federal Government to Cover Costs of Tests for Persons without Symptoms and Modify Quarantine Rules</article-title> (<year>2020</year>). <comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://www.admin.ch/gov/en/start/documentation/media-releases.msg-id-82136.html">https://www.admin.ch/gov/en/start/documentation/media-releases.msg-id-82136.html</ext-link> (Cited July 06, 2022)</comment> (<comment>Accessed March 11, 2022</comment>). </citation>
</ref>
<ref id="B31">
<label>32.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chou</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Dana</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Buckley</surname>
<given-names>DI</given-names>
</name>
<name>
<surname>Selph</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Totten</surname>
<given-names>AM</given-names>
</name>
</person-group>. <article-title>Epidemiology of and Risk Factors for Coronavirus Infection in Health Care Workers: A Living Rapid Review</article-title>. <source>Ann Intern Med</source> (<year>2020</year>) <volume>173</volume>(<issue>2</issue>):<fpage>120</fpage>&#x2013;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.7326/M20-1632</pub-id> </citation>
</ref>
<ref id="B32">
<label>33.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>B&#xf6;ttcher</surname>
<given-names>L</given-names>
</name>
<name>
<surname>D&#x2019;Orsogna</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Chou</surname>
<given-names>T</given-names>
</name>
</person-group>. <article-title>Using Excess Deaths and Testing Statistics to Determine COVID-19 Mortalities</article-title>. <source>Eur J Epidemiol</source> (<year>2021</year>) <volume>36</volume>(<issue>5</issue>):<fpage>545</fpage>&#x2013;<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1007/s10654-021-00748-2</pub-id> </citation>
</ref>
<ref id="B33">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruiz Cantero</surname>
<given-names>MT</given-names>
</name>
</person-group>. <article-title>[Health Statistics and Invisibility by Sex and Gender during the COVID-19 Epidemic]</article-title>. <source>Gac Sanit</source> (<year>2021</year>) <volume>35</volume>:<fpage>95</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.gaceta.2020.04.008</pub-id> </citation>
</ref>
<ref id="B34">
<label>35.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Galbadage</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Peterson</surname>
<given-names>BM</given-names>
</name>
<name>
<surname>Awada</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Buck</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Ramirez</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group> <article-title>Systematic Review and Meta-Analysis of Sex-specific COVID-19 Clinical Outcomes</article-title>. <source>Front Med</source> (<year>2020</year>) <volume>7</volume>:<fpage>348</fpage>. <pub-id pub-id-type="doi">10.3389/fmed.2020.00348</pub-id> </citation>
</ref>
<ref id="B35">
<label>36.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crook</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Raza</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nowell</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Edison</surname>
<given-names>P</given-names>
</name>
</person-group>. <article-title>Long Covid-Mechanisms, Risk Factors, and Management</article-title>. <source>BMJ</source> (<year>2021</year>) <volume>374</volume>:<fpage>n1648</fpage>. <pub-id pub-id-type="doi">10.1136/bmj.n1648</pub-id> </citation>
</ref>
<ref id="B36">
<label>37.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sudre</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Varsavsky</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Graham</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Penfold</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Bowyer</surname>
<given-names>RC</given-names>
</name>
<etal/>
</person-group> <article-title>Attributes and Predictors of Long COVID</article-title>. <source>Nat Med</source> (<year>2021</year>) <volume>27</volume>(<issue>4</issue>):<fpage>626</fpage>&#x2013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1038/s41591-021-01292-y</pub-id> </citation>
</ref>
<ref id="B37">
<label>38.</label>
<citation citation-type="book">
<collab>GH5050</collab>. <source>The Sex, Gender and COVID-19 Project</source> (<year>2021</year>). </citation>
</ref>
<ref id="B38">
<label>39.</label>
<citation citation-type="book">
<collab>World Health Organization</collab>. <source>Taking Sex and Gender into Account in Emerging Infectious Disease Programmes: An Analytical Framework</source>. <publisher-loc>Geneva, Switzerland</publisher-loc>: <publisher-name>World Health Organization</publisher-name> (<year>2011</year>). p. <fpage>80</fpage>. </citation>
</ref>
<ref id="B39">
<label>40.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lewandowski</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lipowska</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Magda</surname>
<given-names>I</given-names>
</name>
</person-group>. <article-title>The Gender Dimension of Occupational Exposure to Contagion in Europe</article-title>. <source>Feminist Econ</source> (<year>2021</year>) <volume>27</volume>(<issue>1-2</issue>):<fpage>48</fpage>&#x2013;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1080/13545701.2021.1880016</pub-id> </citation>
</ref>
<ref id="B40">
<label>41.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clark</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Davila</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Regis</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kraus</surname>
<given-names>S</given-names>
</name>
</person-group>. <article-title>Predictors of COVID-19 Voluntary Compliance Behaviors: An International Investigation</article-title>. <source>Glob Transit</source> (<year>2020</year>) <volume>2</volume>:<fpage>76</fpage>&#x2013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1016/j.glt.2020.06.003</pub-id> </citation>
</ref>
<ref id="B41">
<label>42.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Utzet</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bacigalupe</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Navarro</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Occupational Health, Frontline Workers and COVID-19 Lockdown: New Gender-Related Inequalities?</article-title> <source>J Epidemiol Community Health</source> (<year>2022</year>) <volume>76</volume>:<fpage>537</fpage>&#x2013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1136/jech-2021-217692</pub-id> </citation>
</ref>
<ref id="B42">
<label>43.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Farre</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Fawaz</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Gonzalez</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Graves</surname>
<given-names>J</given-names>
</name>
</person-group>. <source>How the COVID-19 Lockdown Affected Gender Inequality in Paid and Unpaid Work in Spain</source>. <comment>IZA Discussion Paper No. 13434</comment> (<year>2020</year>). <comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://ssrn.com/abstract=3643198">https://ssrn.com/abstract&#x003D;3643198</ext-link>
</comment>. </citation>
</ref>
<ref id="B43">
<label>44.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pokora</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Kutschbach</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Weigl</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Braun</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Epple</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lorenz</surname>
<given-names>E</given-names>
</name>
<etal/>
</person-group> <article-title>Investigation of Superspreading COVID-19 Outbreak Events in Meat and Poultry Processing Plants in Germany: A Cross-Sectional Study</article-title>. <source>PloS One</source> (<year>2021</year>) <volume>16</volume>(<issue>6</issue>):<fpage>e0242456</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0242456</pub-id> </citation>
</ref>
<ref id="B44">
<label>45.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>P&#xe9;rez Romero</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Serrano Pareja</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rumayor Zarzuelo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mata Pariente</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Hernando Garcia</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Characteristics of COVID-19 Cases and Contacts Reported in an Area of Madrid during Beginning of De-escalation</article-title>. <source>Rev Esp Salud Publica</source> (<year>2021</year>) <volume>95</volume>:<fpage>e202107092</fpage>. </citation>
</ref>
<ref id="B45">
<label>46.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Piccoli</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ferrari</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Piumatti</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Jovic</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rodriguez</surname>
<given-names>BF</given-names>
</name>
<name>
<surname>Mele</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group> <article-title>Risk Assessment and Seroprevalence of SARS-CoV-2 Infection in Healthcare Workers of COVID-19 and Non-COVID-19 Hospitals in Southern Switzerland</article-title>. <source>Lancet Reg Health Eur</source> (<year>2021</year>) <volume>1</volume>:<fpage>100013</fpage>. <pub-id pub-id-type="doi">10.1016/j.lanepe.2020.100013</pub-id> </citation>
</ref>
<ref id="B46">
<label>47.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Makarova</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Herzog</surname>
<given-names>W</given-names>
</name>
</person-group>. <article-title>Gender Roles within the Family: A Study across Three Language Regions of Switzerland</article-title>. In: <person-group person-group-type="editor">
<name>
<surname>Safdar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kosakowska-Berezecka</surname>
<given-names>N</given-names>
</name>
</person-group>, editors. <source>Psychology of Gender through the Lens of Culture</source>. <publisher-loc>Cham</publisher-loc>: <publisher-name>Springer</publisher-name> (<year>2015</year>). p. <fpage>239</fpage>&#x2013;<lpage>64</lpage>. </citation>
</ref>
<ref id="B47">
<label>48.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guttierrez</surname>
<given-names>VB</given-names>
</name>
<name>
<surname>Clausen</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Chiolero</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Estimating the Number of Informal Caregivers in One Region of Switzerland: a Population-Based Study</article-title>. <source>Eur J Public Health</source> (<year>2017</year>) <volume>27</volume>. <pub-id pub-id-type="doi">10.1093/eurpub/ckx189.138</pub-id> </citation>
</ref>
<ref id="B48">
<label>49.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rada</surname>
<given-names>AG</given-names>
</name>
</person-group>. <article-title>Covid-19: the Precarious Position of Spain&#x2019;s Nursing Homes</article-title>. <source>BMJ</source> (<year>2020</year>) <volume>369</volume>:<fpage>m1554</fpage>. <pub-id pub-id-type="doi">10.1136/bmj.m1554</pub-id> </citation>
</ref>
<ref id="B49">
<label>50.</label>
<citation citation-type="book">
<collab>Bundesamt f&#xfc;r statistik</collab>. <source>Alters- und Pflegeheime</source>. <publisher-loc>Bern, Switzerland</publisher-loc>: <publisher-name>Bundesamt f&#xfc;r statistik</publisher-name> (<year>2020</year>). </citation>
</ref>
<ref id="B50">
<label>51.</label>
<citation citation-type="book">
<collab>Bundesamt f&#xfc;r statistik</collab>. <source>Im Herbst 2020 hat sich die Zahl der Todesf&#xe4;lle in den Alters- und Pflegeheimen um 80% erh&#xf6;ht</source>. <publisher-loc>Bern, Switzerland</publisher-loc>: <publisher-name>Bundesamt f&#xfc;r statistik</publisher-name> (<year>2021</year>). </citation>
</ref>
<ref id="B51">
<label>52.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Esteve</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cortina</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Cabr&#xe9;</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>L&#x27;&#xe9;cart d&#x27;&#xe2;ge entre &#xe9;poux en Espagne&#xa0;: tendances de long terme, 1922-2006</article-title>. <source>Population</source> (<year>2009</year>) <volume>64</volume>(<issue>1</issue>):<fpage>183</fpage>&#x2013;<lpage>213</lpage>. <pub-id pub-id-type="doi">10.3917/popu.901.0183</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>